Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
melan-A | 0.579 | 0.692 | 1.3E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
spalt like transcription factor 2 | 0.674 | 0.423 | 1.4E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
inhibitor of DNA binding 2 | 0.572 | 0.731 | 0.67 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
TIA1 cytotoxic granule associated RNA binding protein | 0.595 | 0.577 | 0.27 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
Sp1 transcription factor | 0.493 | 0.769 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
cholecystokinin | 0.453 | 0.846 | 3.3E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
cellular communication network factor 3 | 0.554 | 0.615 | 6.6E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
FES proto-oncogene, tyrosine kinase | 0.593 | 0.769 | 3.8E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2003 | 2005 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.050 | None | 1.000 | 1 | 0 | 2001 | 2005 | ||||||||
|
endoglin | 0.446 | 0.846 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
phospholipase D2 | 0.617 | 0.654 | 4.1E-27 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
Wnt family member 1 | 0.495 | 0.769 | 0.33 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.100 | None | 0.923 | 1 | 0 | 1991 | 2005 | ||||||||
|
potassium channel modulatory factor 1 | 0.839 | 0.115 | 0.98 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
growth hormone releasing hormone receptor | 0.568 | 0.692 | 1.0E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
NKD inhibitor of WNT signaling pathway 2 | 0.729 | 0.192 | 1.5E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
iroquois homeobox 2 | 0.769 | 0.192 | 2.2E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.080 | None | 1.000 | 1 | 0 | 1991 | 2007 |